Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

ChosenMed of Beijing Completes B Round for Oncology Precision Medicine

publication date: Apr 22, 2020

ChosenMed Technology, a Beijing oncology precision medicine company, raised "hundreds of millions of yuan" in a Series B round led by Shanghai Lianhe Investment. The company offers products for early screening, prevention and diagnosis of tumors, dynamic monitoring, medication guidance, prognosis evaluation and bioinformatics data analysis. The company claims to have a complete industrial chain for its business, from upstream production of instruments and reagents, to mid-stream third-party oncology medical detection labs, and downstream genetic analysis and medical advice for patients. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital